Fruzaqla
(froo-ZAH-klah)
A drug used to treat adults with colorectal cancer that has spread to other parts of the body and has already been treated with other anticancer therapy. It is also being studied in the treatment of other types of cancer. Fruzaqla blocks a protein called VEGFR, which may prevent the growth of new blood vessels that tumors need to grow and may kill cancer cells. It is a type of antiangiogenesis agent and a type of kinase inhibitor. Also called fruquintinib.